Company Profile
Daicel provides the materials, medical/healthcare, smart, safety, and engineering plastics businesses in Japan and globally. The company offers medical/healthcare products, including BELLOCEA S7, a spherical cellulose acetate particle.
Its portfolio also includes FLAVOCELL S-Equol, Urolithin A, polyglycerols, konjac ceramide, excipients for foods, chiral columns and reagents, and Actranza lab, as well as separation and analytical services Performance films, solvents for electronic materials, cycloaliphatic epoxies, polymers for photoresists, optical lenses, and caprolactone derivatives.
Its portfolio also includes functional films and materials used in smartphones, PCs, TVs, and in-vehicle displays, polymers and solvents, and lenses used in VR, smartphones and various sensors. Additionally, it offers airbags inflators, pyro-fuses, and gas generators for seat belt pretensioners.
Its portfolio also includes acetic acid, acetic acid derivatives, acetate tow, ketene / diketene derivatives, cellulose acetate for LCD optical films, amines, and 1,3-butylene glycol, and reverse osmosis membrane and ultrafiltration membrane products
Water treatment systems, as well as Engineering plastics comprising polyacetal, polybutylene terephthalate, polyphenylene sulfide, liquid crystal polymer, and cyclic olefin copolymer.
Its portfolio also includes AS resin, acetate plastics, water-soluble polymers, and barrier films for packaging, ABS resins, various polymer alloys, plastic compounds, Polyamide-12 and PEEK resin, and various molded containers.
Its products serve transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. Incorporated in 1919 and headquartered in Osaka, Japan, Daicel was formerly known as Daicel Chemical Industries, Ltd. before rebranding in October 2011.